Quadratus Lumborum vs Erector Spinae Blocks for Postoperative Hip Surgery Pain
Trial Summary
What is the purpose of this trial?
This trial is comparing two types of nerve blocks, ESB and QLB, used with a lumbar plexus block to manage pain in young patients after hip surgery. The goal is to see if there is any difference in pain relief and opioid use between the two methods. Both blocks aim to reduce pain by numbing specific nerves, potentially lowering the need for opioids. Quadratus lumborum block (QLB) has been increasingly used for pain control following hip surgeries, showing effectiveness in reducing postoperative pain and opioid consumption.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have been treated with opioids in the last 2 months, you may not be eligible to participate.
What data supports the effectiveness of the treatment Erector Spinae Block and Quadratus Lumborum Block for postoperative hip surgery pain?
Research shows that both Erector Spinae Plane Block and Quadratus Lumborum Block have been effective in reducing pain after various surgeries, including hip and femur operations, caesarean sections, and abdominal surgeries. These treatments help manage pain by blocking nerve signals in specific areas of the body.12345
Is it safe to use Quadratus Lumborum and Erector Spinae Blocks for pain relief after surgery?
How do Quadratus Lumborum and Erector Spinae Blocks differ from other treatments for postoperative hip surgery pain?
Quadratus Lumborum and Erector Spinae Blocks are unique because they are types of nerve blocks that target specific areas in the back to provide pain relief after surgery. Unlike general pain medications that affect the whole body, these blocks work by numbing the nerves around the surgical site, potentially offering more targeted and effective pain control with fewer side effects.12346
Research Team
ROLAND BRUSSEAU, MD
Principal Investigator
Boston Children's Hospital
Eligibility Criteria
This trial is for young individuals aged 15-30 with developmental acetabular dysplasia experiencing hip pain, who are undergoing unilateral hip surgery. They must be in good health (ASA I - III status) and not overweight (BMI ≤ 35). Those with blood clotting issues, severe neurodevelopmental delays, chronic pain syndromes, recent opioid use, or without parental/patient consent are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a single-shot erector spinae block or quadratus lumborum block in conjunction with continuous lumbar plexus block for postoperative analgesia
Follow-up
Participants are monitored for pain control and adverse events post-surgery
Treatment Details
Interventions
- Erector Spinae Block
- Quadratus Lumborum Block
- Ropivacaine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Children's Hospital
Lead Sponsor